
Founder of Livongo Health, which merged with Teladoc in a landmark $18.5 billion deal, Tullman is now building Transcarent's direct-to-employer platform delivering curated cancer, surgical, and primary care as a workplace benefit.
Glen Tullman is Executive Chairman of Transcarent and Founder of Livongo Health, the digital chronic disease management company that merged with Teladoc Health in 2020 in an $18.5 billion deal.
Tullman founded Livongo after his son was diagnosed with type 1 diabetes. Previously, he was CEO of Allscripts Healthcare Solutions, which he grew from $30 million to $1.4 billion in revenue. Transcarent provides curated healthcare services as an employer benefit.

An invitation, extended to Powered readers.